The Pittcon sponsors, Spectroscopy Society of Pittsburgh (SSP) and Society of Analytical Chemists of Pittsburgh (SACP), are pleased to announce the call for nominations for four prestigious annual awards that will be presented at Pittcon 2017 in Chicago, Illinois.
For complete requirements, guidelines and submission instructions for all the awards, please visit www.pittcon.org
SSP Call for Nominations: The Pittsburgh Spectroscopy Award is in recognition of an individual’s outstanding contributions in the field of applied spectroscopy...
New name reflects mandate of the Catapult to serve the industry
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official change of its name to the Cell and Gene Therapy Catapult. The new name more accurately reflects the activities of the organisation, the boom in gene modified cell therapies, and the wave of direct gene therapies...
World leading pioneer on drug discovery through open innovation, joins the stem cell disease model specialists
Axol Bioscience, a biotechnology company specialising in the use of stem cell technology to manufacture disease relevant cell based assay systems for the drug discovery industry, today appointed Prof Chas Bountra to their Scientific Advisory Board (SAB). Chas Bountra is recognised for his open access approach to drug discovery and has made several noteworthy contributions to the field. A pioneer in the identification and...
Redipor® prepared media to be supplied directly to customers
Cherwell Laboratories, specialists in cleanroom microbiology solutions for the pharmaceutical and related industries, will now be delivering their Redipor® prepared media directly to customers in the Republic of Ireland. Cherwell are renowned for offering a flexible supply of quality prepared microbiological media products, and this development will now enable Cherwell to offer improved service and support to customers in the...
North American Liquid Chromatography Reagents Market by Type (HPLC Reagents, LPLC Reagents, UHPLC Reagents), by End-User (Pharmaceuticals, Academics, Environmental Biotechnology, Food & Beverage, Hospitals, Cosmetics, Nutraceuticals) - Forecast to 2019
The North American liquid chromatography reagents market is estimated to grow at a CAGR of 9.3% from 2014 to 2019. The U.S. accounted for the largest share of this market, which is expected to grow at a CAGR of 9.4%. The North American liquid chromatography reagents market holds high potential for growth in future due to the growth in investments in the life sciences and biotechnology segment, along with advances in...
Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced the appointment of Professor Steve Howell to the Board of Directors.
Steve has over 20 years of experience building and growing life science enterprises, including founding life science investment company Innova Partnerships in 2006. Prior to this he was Director of Business Development at Alere Inc, and Research Director at Unipath Ltd, after joining Unilever Plc. Steve is currently a non-executive director of Reminova Ltd and Relaymed. He is visiting Professor of Commercial Innovation at Kings...
Aragen Bioscience, Inc. (Aragen), leading contract research organization specializing in the study and early development of biologic and diagnostic products, has initiated construction on a new, state of the art research facility.
Dedicated to the testing and characterization of novel therapeutics and vaccines, the new research space will add 15,000 sq.ft. to Aragen’s existing laboratories and will double capacity for diverse efficacy studies. Such studies are critical to the development of products that improve the diagnosis, treatment and prevention of disease including for example, fibrotic and infectious disease, oncology and other immunologically...
Protagen AG, a company concerned with the development of advanced diagnostic tools to address some of the most severe autoimmune diseases, has today announced that it will join the RA-MAP Consortium.
The overarching goal of the Consortium is to identify the key predictors of clinical response and remission in RA patients, and to identify those individuals at high risk of developing Rheumatoid Arthritis (RA). RA is one of the most common auto-immune diseases in the world. RA patients may experience difficulties with everyday tasks and restricted work options. Thus, RA has massive health economic implications. Early intervention...
Leica Biosystems, a global leader in anatomic pathology solutions and workflow automation, and Advanced Cell Diagnostics, Inc. (ACD), a world leader in RNA biomarker analysis for precision medicine, today announced a comprehensive partnership to develop and commercialize tissue-based diagnostic tests based on ACD's RNAscope in situ hybridization (ISH) assays on Leica Biosystems' BOND clinical advanced staining instruments.
The agreement supports Leica Biosystems' development and commercialization of fully automated RNAscope-based companion diagnostic (CDx) tests in partnership with biopharmaceutical companies. The combination of ACD's RNAscope technology with Leica Biosystems' fully automated pathology solutions allows companies and laboratories in clinical markets to integrate the power of new RNA-based biomarker tests into the...
Pharma and cosmetics multinational selects BioAscent as central hub for storage and logistics of extensive plant natural extracts collection
BioAscent Discovery, announces a new collaboration with pharmaceutical and cosmetics multinational, Pierre Fabre, as part of an open innovation initiative promoting the use of natural products in life sciences. Pierre Fabre’s library of ca. 15,000 plant extracts is the largest private collection of its type in the world. BioAscent’s state-of-the-art compound management and logistics facility is ideally placed to share out such an extract...
Themis Bioscience GmbH, a leading company developing prophylactic vaccines against emerging tropical infectious diseases, today announced the appointment of two new leadership members, Dr. Philippe Dro and Dr. Christian Mandl.
The appointment follows in the wake of the successful completion of a phase I clinical trial of the company's Chikungunya vaccine, and so Themis is heading for hot times – and is growing steadily. Dr. Philippe Dro, a renowned life science entrepreneur will join the Board of Directors. The Scientific Advisory Board of Themis Bioscience will in the future benefit from the outstanding experience of Dr. Christian Mandl as chai....
Strategic partnership creates a world leading CDMO offer to supply AAV-based viral vectors, an increasingly attractive therapeutic platform for gene therapy
Novasep, a leading supplier of services and technologies for the life sciences industry, and Advanced Biotherapeutics Consulting (ABC), a service provider that leverages the expertise of the Nantes Gene Therapy Institute led by Philippe Moullier, MD, PhD, today announce they have entered into a CDMO (Contract Development Manufacturing Organization) partnership. This partnership enables the companies to provide their respective...
Centauri Therapeutics Ltd, a biotechnology company focused on the treatment of infectious diseases, announced today that it has acquired the Alphamer technology for drug discovery and development from Altermune Technologies LLC.
Centauri Therapeutics acquired full rights to patents, proprietary compounds, know-how and collaboration/licence agreements from Altermune in exchange for an undisclosed fee. The company has also announced that it has appointed Dr Clive Dix as Chairman and secured the first tranche of a £3M raise to develop its first lead candidate. The funding will be used to develop its first lead Alphamers against anti-microbial resistant...
The stem cell disease model specialists recruit leading biologist, Prof Xianmin Zeng as Chief Scientific Officer
Axol Bioscience, a biotechnology company, specialising in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced Prof Xianmin Zeng, PhD as Chief Scientific Officer (CSO). Prof Zeng is an accomplished biologist with over 15 years of academic expertise in the development of stem cell technologies and its applications. A biotech entrepreneur with an extensive...
Synpromics Ltd, a leading synthetic biology company, and The Cell Therapy Catapult, the UK organisation accelerating the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announce the launch of a collaboration to remove a major barrier to the development of the cell and gene therapy industry by reducing the cost and increasing the scale and efficiency of viral vector manufacturing.
The collaboration will use Synpromics' synthetic promoter design technology, and the Cell Therapy Catapult's flexible manufacturing platform to create stable producer cell lines for the high titre and large scale manufacture of viral vectors. The work will be part funded by a £2m grant from Innovate UK, the UK’s innovation agency. Viral vectors are a crucial tool needed to modify patient’s cells to create a therapeutic effect...
Genomics plc, a leading analysis company developing algorithms and software solutions to uncover the relationships between genetic variation and human disease, today announced that Sekar Kathiresan, M.D., a renowned clinical cardiologist and human geneticist, has joined Genomics plc’s newly-formed Scientific Advisory Board (SAB) as chair, with immediate effect.
Dr Kathiresan is one of the world leaders in the genetics of heart disease. He is the director of preventive cardiology at Massachusetts General Hospital, an associate member in the Broad Institute’s Program in Medical and Population Genetics, and an associate professor of medicine at Harvard Medical School. He received his B.A. in history and graduated summa cum laude from the University of Pennsylvania in 1992. He received his...
Irvine Scientific, a world leader in the innovation and manufacture of cell culture media, reagents, and medical devices for industrial, clinical and research applications, today announced it has acquired BioCare Europe S.r.l. (BioCare).
Based in Rome, Italy, BioCare is a leading distributor of in vitro fertilization (IVF) media, medical devices, and equipment. Irvine Scientific provides the IVF market with cGMP cell culture media which is unrivalled in performance and quality. Supporting IVF hospitals and clinics worldwide, Irvine Scientific has been building a sales presence in Europe over the last several years, focused mainly in the UK, France, and Germany. BioCare is...
Metrohm USA and the University of Maryland School of Pharmacy have recently formed a mutually beneficial partnership.
The alliance will bring state-of-the-art analytical instrumentation and software to the School to be used by students and faculty in a variety of disciplines. The presence of Metrohm at the School of Pharmacy will foster collaboration between Metrohm scientists and the renowned research and education leaders at the School. Collaborative work is already under way in the laboratory of Dr. Stephen Hoag, Professor of Pharmaceutical...
Interest in flow chemistry systems has doubled since 2010 according to UK-based flow chemistry engineering specialists Vapourtec (Cambridge, UK) who experienced a further 15% increase in turnover in 2015.
Vapourtec's turnover over the past 5 years has increased by 100% mirroring key industry reports that reveal an ever growing interest and engagement by chemists around the world in continuous process technology. Vapourtec founder and MD Duncan Guthrie commented: "We've experienced another rapid year of growth and this reflects growing awareness of the benefits and the impressive economies of scale that can be delivered by flow chemistry...
NanoHybrids Inc., a nanotechnology and molecular imaging company, recently received $225,000 from the National Cancer Institute (NCI) to develop a new breakthrough immunohistochemistry (IHC) technology.
The project builds on NanoHybrids expertise producing high quality gold nanoparticles that enable innovative approaches to imaging. With this Phase I Small Business Innovation Research (SBIR) grant, NanoHybrids will develop a new photoacoustic microscopy platform to quantitatively assess biomarker distribution in biopsied and histological human samples.
Sakura Finetek USA, Inc. today announced the acquisition of Genemed Biotechnologies Inc.’s (Genemed) tissue-based Advanced Staining business for cancer detection, diagnosis and monitoring.
The deal is expected to be closed by December 31st, 2015. Financial terms of the acquisition were not disclosed. “We are pleased to add Genemed’s highly skilled and expert personnel, production facility and their extensive catalog of antibodies, probes and detection chemistry to Sakura’s product portfolio. The product portfolio offered by Genemed is a perfect complement to Sakura’s hardware and software...
An internationally renowned gene therapy research team has won a $200,000 CytoFLEX Flow Cytometer from Beckman Coulter Life Sciences.
The contest was designed to explore innovative research solutions involving flow cytometry. The winning team, headed up by Dr Martin Pulé, is from UCL Cancer Institute at University College London, UK. Their submission focused on capitalizing on the power of multi-parameter flow cytometry to expand understanding of the molecular mechanisms of cancer at the single cell level. The CytoFLEX Flow Cytometer measures up to...
For complete requirements, guidelines and submission instructions for all the awards, please visit www.pittcon.org
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official change of its name to the Cell and Gene Therapy Catapult. The new name more accurately reflects the activities of the organisation, the boom in gene modified cell therapies, and the wave of direct gene therapies...
Axol Bioscience, a biotechnology company specialising in the use of stem cell technology to manufacture disease relevant cell based assay systems for the drug discovery industry, today appointed Prof Chas Bountra to their Scientific Advisory Board (SAB). Chas Bountra is recognised for his open access approach to drug discovery and has made several noteworthy contributions to the field. A pioneer in the identification and...
Cherwell Laboratories
The North American liquid chromatography reagents market is estimated to grow at a CAGR of 9.3% from 2014 to 2019. The U.S. accounted for the largest share of this market, which is expected to grow at a CAGR of 9.4%. The North American liquid chromatography reagents market holds high potential for growth in future due to the growth in investments in the life sciences and biotechnology segment, along with advances in...
Steve has over 20 years of experience building and growing life science enterprises, including founding life science investment company Innova Partnerships in 2006. Prior to this he was Director of Business Development at Alere Inc, and Research Director at Unipath Ltd, after joining Unilever Plc. Steve is currently a non-executive director of Reminova Ltd and Relaymed. He is visiting Professor of Commercial Innovation at Kings...
Dedicated to the testing and characterization of novel therapeutics and vaccines, the new research space will add 15,000 sq.ft. to Aragen’s existing laboratories and will double capacity for diverse efficacy studies. Such studies are critical to the development of products that improve the diagnosis, treatment and prevention of disease including for example, fibrotic and infectious disease, oncology and other immunologically...
The overarching goal of the Consortium is to identify the key predictors of clinical response and remission in RA patients, and to identify those individuals at high risk of developing Rheumatoid Arthritis (RA). RA is one of the most common auto-immune diseases in the world. RA patients may experience difficulties with everyday tasks and restricted work options. Thus, RA has massive health economic implications. Early intervention...
The agreement supports Leica Biosystems' development and commercialization of fully automated RNAscope-based companion diagnostic (CDx) tests in partnership with biopharmaceutical companies. The combination of ACD's RNAscope technology with Leica Biosystems' fully automated pathology solutions allows companies and laboratories in clinical markets to integrate the power of new RNA-based biomarker tests into the...
BioAscent Discovery, announces a new collaboration with pharmaceutical and cosmetics multinational, Pierre Fabre, as part of an open innovation initiative promoting the use of natural products in life sciences. Pierre Fabre’s library of ca. 15,000 plant extracts is the largest private collection of its type in the world. BioAscent’s state-of-the-art compound management and logistics facility is ideally placed to share out such an extract...
The appointment follows in the wake of the successful completion of a phase I clinical trial of the company's Chikungunya vaccine, and so Themis is heading for hot times – and is growing steadily. Dr. Philippe Dro, a renowned life science entrepreneur will join the Board of Directors. The Scientific Advisory Board of Themis Bioscience will in the future benefit from the outstanding experience of Dr. Christian Mandl as chai....
Novasep, a leading supplier of services and technologies for the life sciences industry, and Advanced Biotherapeutics Consulting (ABC), a service provider that leverages the expertise of the Nantes Gene Therapy Institute led by Philippe Moullier, MD, PhD, today announce they have entered into a CDMO (Contract Development Manufacturing Organization) partnership. This partnership enables the companies to provide their respective...
Centauri Therapeutics acquired full rights to patents, proprietary compounds, know-how and collaboration/licence agreements from Altermune in exchange for an undisclosed fee. 
Axol Bioscience, a biotechnology company, specialising in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced Prof Xianmin Zeng, PhD as Chief Scientific Officer (CSO). Prof Zeng is an accomplished biologist with over 15 years of academic expertise in the development of stem cell technologies and its applications. A biotech entrepreneur with an extensive...
The collaboration will use Synpromics' synthetic promoter design technology, and the Cell Therapy Catapult's flexible manufacturing platform to create stable producer cell lines for the high titre and large scale manufacture of viral vectors. The work will be part funded by a £2m grant from Innovate UK, the UK’s innovation agency. 
Dr Kathiresan is one of the world leaders in the genetics of heart disease. He is the director of preventive cardiology at Massachusetts General Hospital, an associate member in the Broad Institute’s Program in Medical and Population Genetics, and an associate professor of medicine at Harvard Medical School. He received his B.A. in history and graduated summa cum laude from the University of Pennsylvania in 1992. He received his...
Based in Rome, Italy, BioCare is a leading distributor of in vitro fertilization (IVF) media, medical devices, and equipment. Irvine Scientific provides the IVF market with cGMP cell culture media which is unrivalled in performance and quality. Supporting IVF hospitals and clinics worldwide, Irvine Scientific has been building a sales presence in Europe over the last several years, focused mainly in the UK, France, and Germany. BioCare is...
The alliance will bring state-of-the-art analytical instrumentation and software to the School to be used by students and faculty in a variety of disciplines. The presence of Metrohm at the School of Pharmacy will foster collaboration between Metrohm scientists and the renowned research and education leaders at the School. Collaborative work is already under way in the laboratory of Dr. Stephen Hoag, Professor of Pharmaceutical...
Vapourtec's turnover over the past 5 years has increased by 100% mirroring key industry reports that reveal an ever growing interest and engagement by chemists around the world in continuous process technology. Vapourtec founder and MD Duncan Guthrie commented: "We've experienced another rapid year of growth and this reflects growing awareness of the benefits and the impressive economies of scale that can be delivered by flow chemistry...
The deal is expected to be closed by December 31st, 2015. Financial terms of the acquisition were not disclosed. “We are pleased to add Genemed’s highly skilled and expert personnel, production facility and their extensive catalog of antibodies, probes and detection chemistry to Sakura’s product portfolio. The product portfolio offered by Genemed is a perfect complement to Sakura’s hardware and software...
The contest was designed to explore innovative research solutions involving flow cytometry. The winning team, headed up by Dr Martin Pulé, is from UCL Cancer Institute at University College London, UK. Their submission focused on capitalizing on the power of multi-parameter flow cytometry to expand understanding of the molecular mechanisms of cancer at the single cell level. The CytoFLEX Flow Cytometer measures up to...